STIRIPENTOL BILLEV 250mg capsules medication leaflet

N03AX17 stiripentol • Nervous system | Antiepileptics | Other antiepileptics

Stiripentol is an antiepileptic medication used as adjunctive therapy for the treatment of Dravet syndrome, a rare form of epilepsy. It works by enhancing the effects of other antiepileptic drugs, such as clobazam and valproate, and by reducing neuronal excitability.

The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to adhere to the treatment regimen and avoid abrupt discontinuation.

Patients should be aware of potential side effects, such as drowsiness, nausea, or decreased appetite. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, nausea, and decreased appetite. In rare cases, severe reactions such as neutropenia or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about STIRIPENTOL BILLEV 250mg

Substance: stiripentol

Date of last drug list: 01-12-2024

Commercial code: W70728003

Concentration: 250mg

Pharmaceutical form: capsules

Quantity: 90

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MISOM LABS LIMITED - MALTA

Holder: BILLEV PHARMA APS - DANEMARCA

Number: 15687/2024/03

Shelf life: 3 years

Pharmaceutical forms available for stiripentol

Concentrations available for stiripentol

250mg, 500mg